Shanghai Synvida Biotechnology Co.,ltd.
Clinical trials sponsored by Shanghai Synvida Biotechnology Co.,ltd., explained in plain language.
-
New hope for scarred lungs: experimental drug enters patient testing
Disease control Recruiting nowThis study is testing an experimental drug called SV001 in people with idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. The main goal is to check if the drug is safe and how the body processes it. Researchers will give the drug to 48 patients and compare them…
Phase: PHASE2 • Sponsor: Shanghai Synvida Biotechnology Co.,Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
First human tests begin for potential lung disease treatment
Knowledge-focused Recruiting nowThis is an early safety study for a new drug called SV001, which is being developed to treat a serious lung-scarring disease. The study will involve 53 healthy Chinese adult volunteers who will receive a single dose of the drug or a placebo. The main goal is to see how safe the d…
Phase: EARLY_PHASE1 • Sponsor: Shanghai Synvida Biotechnology Co.,Ltd. • Aim: Knowledge-focused
Last updated Apr 04, 2026 05:06 UTC